Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON34415
NL-OMON34415
Completed
Not Applicable

An open-label, multiple dose, randomized, two-way crossover study to evaluate the effects of BGG492 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female volunteers - CBGG492A2115

ovartis0 sites24 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEpilepsieEpilepsiafalling disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsie
Sponsor
ovartis
Enrollment
24
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ovartis

Eligibility Criteria

Inclusion Criteria

  • •Young females, 18\-40 years, BMI 18\-29 kg/m2, non\-smokers, OC\-user

Exclusion Criteria

  • •Clinical significant abnormalities during screening and baseline

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
A randomized, open-labeled, multiple-dose, two-way crossover design with two-period, two-treatment, two-sequence steady-state bioequivalence study of Venlafaxine Hydrochloride Extended-Release Capsules 150 mg and Efexor XR 150 mg Capsules in healthy, adult, Thai volunteers under fed conditioHealthy subjectsBioequivalence Venlafaxine Hydrochloride Extended-Release Capsules 150 mg
TCTR20240706012Bio-innova Co., Ltd.44
Completed
Not Applicable
Azathioprine Bioequivalence study in Rheumatoid ArthritisHealth Condition 1: null- Rheumatoid Arthritis
CTRI/2010/091/000070Orion Pharma42
Completed
Not Applicable
Bioequivalence study of Vigabatrin Tablets 500 mg in refractory complex partial-seizure adult patients on Vigabatrin adjunctive therapy.Health Condition 1: G402- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
CTRI/2020/11/029355Amneal Pharmaceuticals LLC36
Not yet recruiting
Not Applicable
Study to investigate the effect of tamsulosin on the pharmacokinetic properties of tadalafil after oral administration in healthy male volunteersDiseases of The genitoruinary system
KCT0001243Chong Kun Dang16
Not yet recruiting
Not Applicable
Study to investigate the effect of tadalafil the pharmacokinetic properties of tamsulosinon after oral administration in healthy male volunteersDiseases of The genitoruinary system
KCT0001245Chong Kun Dang28